The ARTS Program offers the opportunity to combine clinical training with advanced research training to complete a PhD degree during or upon completion of residency or clinical fellowship. The program begins with one or more years of postgraduate clinical training, followed by research training in a graduate program in Stanford University's Schools of Medicine, Engineering, or Humanities and Sciences.
Residents/clinical fellows admitted to the program complete clinical training toward board certification in internal medicine, its subspecialties (cardiovascular medicine, hematology, immunology and rheumatology, infectious diseases, nephrology, oncology, pulmonary and critical care medicine), surgical disciplines (neurosurgery, obstetrics and gynecology, surgery and urology), or non-surgical disciplines (neurology, pediatrics, psychiatry, radiation oncology and radiology).
The Cancer-Translational Nanotechnology Training (Cancer-TNT) Program, is a diverse and synergistic 3-year training program bringing together 25 faculty and 9 Departments from three schools to train the next generation of interdisciplinary leaders who will pursue challenges in cancer research and clinical translation. Cancer nanotechnology is a rapidly growing field that requires close interactions of researchers from disparate fields of science, such as chemistry, materials science, cancer biology, and medicine.
Postdoctoral trainees will cross train to develop interdisciplinary researchers in cancer nanotechnology translation. Our trainees' skill sets will bridge multiple disciplines such as chemistry, molecular biology, bioengineering, molecular imaging, nanoengineering, and clinical cancer medicine. Trainees will be able to advance cancer research, diagnosis, and management.
The Multi-Disciplinary Training Program in Cardiovascular Imaging @ Stanford (CVIS) is funded by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health to bring together post-doctoral fellows and faculty from three complementary areas – clinical, engineering, and molecular imaging – to train the next generation of CV imaging investigators for successful careers. With the impact of cardiovascular disease on US and world health and the rapid advances in imaging technologies and cardiovascular biology, it is critical that fellows be provided a broad, multi-disciplinary, and collaborative training program to foster their ability to translate CV imaging research into clinical application.
The CVIS trains up to 4 post-doctoral fellows from MD and PhD backgrounds together over a two year period, combining CV imaging research with a structured educational program. There are over 20 faculty mentors from the Schools of Medicine and Engineering, including Cardiovascular Medicine, Radiology, Molecular Imaging, Electrical Engineering, and Bioengineering.
Our mission is to train the next generation of researchers in the development and clinical translation of advanced techniques for cancer imaging and its application. With funding from the National Cancer Institute (NCI), we are able to offer the Stanford Cancer Imaging Training (SCIT) Program to well-qualified applicants.
This T32 training program is the evolution of our longstanding program, formerly known as "Advanced Techniques for Cancer Imaging and Detection," established and led by our former Chair Dr. Gary M. Glazer in 1992.
SCIT is a two-year program training five fellows (roughly half PhD / half MD) per year over a five year funding cycle. Drs. Sandy Napel, PhD, and Bruce Daniel MD, lead this newly redesigned program, featuring 24 mentors with independent cancer-focused or -related funding, and seven (five internal / two external) distinguished program advisors. Our strengthened required coursework component includes two courses in the clinical/cancer sciences, two in imaging science, one in biostatistics, one in medical ethics (“Responsible Conduct of Research”), and attendance at a minimum of six multidisciplinary tumor boards. In addition, trainees can select from a multitude of electives offered by various Stanford University Departments, e.g., Radiology, Radiation Oncology, Bioengineering, Biomedical Informatics, and Cancer Systems Biology. The primary focus of the program is participation in a mentored cancer-imaging research project aimed at publication in peer-reviewed journals, and presentation at National meetings. We especially feature “paired mentorship,” in which each trainee is teamed with both a basic-science and physician mentor, to provide guidance in course and research-topic selection, and in performing clinically-relevant cancer imaging research.
The Stanford Molecular Imaging Scholars (SMIS) program is a diverse training program bringing together more than thirteen Departments, predominantly from the Stanford Schools of Medicine and Engineering, in order to train the next generation of interdisciplinary leaders in molecular imaging. Oncologic molecular imaging is a rapidly growing area within molecular imaging which combines the disciplines of chemistry, cell/molecular biology, molecular pharmacology, physics, bioengineering, imaging sciences, and clinical medicine to advance cancer research, diagnosis and management.
The goals of SMIS are to train postdoctoral fellows through a diverse group of over 40 basic science and clinical faculty mentors representing 8 program areas, incorporating formal courses in molecular imaging, molecular pharmacology, cancer biology, cancer immunology, virology, and gene therapy, with a clinical component including hematology/oncology rounds.